Treatment Center News

Addenbrooke’s Hospital Begins Treating Patients on Second TomoTherapy Cancer Treatment System

TomoTherapy Incorporated announced today that Addenbrooke’s Hospital, which is run by the Cambridge University Hospitals National Health Service (NHS) Foundation Trust, recently installed and began treating patients on its second TomoTherapy® radiation therapy system. “The TomoTherapy platform has proven to be a highly efficient solution for daily image-guided radiotherapy with positional correction, and for the delivery of sophisticated treatment plans using high-quality intensity-modulated radiotherapy,” said Neil Burnet, a consultant oncologist at Addenbrooke’s. “With our second TomoTherapy system now in operation, we are able to offer this extraordinary treatment to more patients, expanding our ability to treat prostate cancer and more complex cases.” (2 Feb 2010) Read More

View all treatment center news

Company News

TomoTherapy Announces Fourth Quarter Financial Results

TomoTherapy Incorporated (NASDAQ: TOMO), producer of the Hi·Art® treatment system and other products for advanced radiation therapy, today released financial results for the fourth quarter ended December 31, 2009. (17 Feb 2010) Read More

View all company news